Ontology highlight
ABSTRACT: Importance
Despite efforts to improve the quality of care for patients with atherosclerotic cardiovascular disease (ASCVD), it is unclear whether the US has made progress in reducing racial and ethnic differences in utilization of guideline-recommended therapies for secondary prevention.Objective
To evaluate 21-year trends in racial and ethnic differences in utilization of guideline-recommended pharmacological medications and lifestyle modifications among US adults with ASCVD.Design, setting, and participants
This cross-sectional study includes data from the National Health and Nutrition Examination Survey between 1999 and 2020. Eligible participants were adults aged 18 years or older with a history of ASCVD. Data were analyzed between March 2022 and May 2023.Ex
SUBMITTER: Lu Y
PROVIDER: S-EPMC10692850 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature